321 related articles for article (PubMed ID: 27503233)
1.
Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
[TBL] [Abstract][Full Text] [Related]
2. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
4. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
[TBL] [Abstract][Full Text] [Related]
5. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
[TBL] [Abstract][Full Text] [Related]
7. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
Dimakou K; Triantafillidou C; Toumbis M; Tsikritsaki K; Malagari K; Bakakos P
Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814
[TBL] [Abstract][Full Text] [Related]
8. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
[No Abstract] [Full Text] [Related]
9. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
[TBL] [Abstract][Full Text] [Related]
10. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
[TBL] [Abstract][Full Text] [Related]
11. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
Venning V; Bartlett J; Jayaram L
Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
[TBL] [Abstract][Full Text] [Related]
12. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
[TBL] [Abstract][Full Text] [Related]
13. Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis.
Guan WJ; Gao YH; Li HM; Yuan JJ; Chen RC; Zhong NS
PLoS One; 2015; 10(9):e0137348. PubMed ID: 26340660
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.
Martínez-García MA; Soler-Cataluña JJ; Perpiñá-Tordera M; Román-Sánchez P; Soriano J
Chest; 2007 Nov; 132(5):1565-72. PubMed ID: 17998359
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
17. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.
Martínez-García MÁ; Vendrell M; Girón R; Máiz-Carro L; de la Rosa Carrillo D; de Gracia J; Olveira C
Ann Am Thorac Soc; 2016 Sep; 13(9):1468-75. PubMed ID: 27348199
[TBL] [Abstract][Full Text] [Related]
18. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism.
Tong M; McHardy I; Ruegger P; Goudarzi M; Kashyap PC; Haritunians T; Li X; Graeber TG; Schwager E; Huttenhower C; Fornace AJ; Sonnenburg JL; McGovern DP; Borneman J; Braun J
ISME J; 2014 Nov; 8(11):2193-206. PubMed ID: 24781901
[TBL] [Abstract][Full Text] [Related]
19. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.
Tsikrika S; Dimakou K; Papaioannou AI; Hillas G; Thanos L; Kostikas K; Loukides S; Papiris S; Koulouris N; Bakakos P
Cytokine; 2017 Nov; 99():281-286. PubMed ID: 28863927
[TBL] [Abstract][Full Text] [Related]
20. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
